sargramostim
Showing 1 - 25 of 170
Parkinson's Disease and Parkinsonism Trial in Omaha (Sargramostim)
Not yet recruiting
- Parkinson's Disease and Parkinsonism
- Sargramostim
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Dec 22, 2022
Alzheimer Trial in Aurora (Sargramostim, Saline - comparator)
Recruiting
- Alzheimer Disease
- Sargramostim
- Saline - placebo comparator
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 19, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- Sargramostim
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022
Parkinson Disease Trial in Omaha (sargramostim)
Active, not recruiting
- Parkinson Disease
- sargramostim
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 19, 2022
Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)
Recruiting
- Transplant-Related Hematologic Malignancy
- Sargramostim
- Control Arm
-
Atlanta, GeorgiaNorthside Hospital
Oct 19, 2022
COVID-19, SARS-CoV-2 Trial in United States (Sargramostim, Standard of care)
Completed
- COVID-19
- SARS-CoV-2
- Sargramostim
- Standard of care
-
Fullerton, California
- +10 more
Feb 16, 2022
COVID-19 Trial in Japan (Sargramostim, Placebo)
Completed
- COVID-19
- Sargramostim
- Placebo
-
Narita City, Chiba, Japan
- +6 more
Nov 1, 2021
Autoimmune Pulmonary Alveolar Proteinosis Trial in Los Altos, Cincinnati (Sargramostim)
Completed
- Autoimmune Pulmonary Alveolar Proteinosis
- Sargramostim
-
Los Altos, California
- +1 more
Aug 2, 2021
Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)
Recruiting
- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Natural Killer Cells
- +4 more
-
Columbus, OhioNationwide Children's Hospital
Oct 26, 2022
Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,
Active, not recruiting
- Partial Response of Multiple Myeloma or Plasma Cell Leukemia
- Plasma Cell Myeloma
- Incomplete Freund's Adjuvant
- +4 more
-
Buffalo, New York
- +1 more
Dec 12, 2022
COVID-19 Trial in Belgium (Sargramostim, Control)
Completed
- COVID-19
- Sargramostim
- Control
-
Brugge, Belgium
- +3 more
Mar 1, 2021
Covid19, SARS-CoV Infection Trial in Argentina, United States (Sargramostim, Placebo)
Completed
- Covid19
- SARS-CoV Infection
- Sargramostim
- Placebo
-
Phoenix, Arizona
- +36 more
Feb 22, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Biliary Cancer Trial in San Francisco (Pembrolizumab, Sargramostim)
Completed
- Biliary Cancer
- Pembrolizumab
- Sargramostim
-
San Francisco, CaliforniaUniversity of California San Francisco
Jan 21, 2022
Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)
Active, not recruiting
- Mesothelioma
- +2 more
- Galinpepimut-S
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 23, 2022
Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +3 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +8 more
-
Los Angeles, CaliforniaUSC CRS
Oct 26, 2021
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2b
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 26, 2021
HIV, Cytopenias Trial in Buffalo (Zidovudine, Sargramostim)
Completed
- HIV Infections
- Cytopenias
- Zidovudine
- Sargramostim
-
Buffalo, New YorkSUNY / Erie County Med Ctr at Buffalo
Oct 27, 2021
Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)
Withdrawn
- Lymphoma
- rituximab
- +7 more
-
Washington, District of Columbia
- +1 more
Oct 19, 2021
Solid Tumor Trial in New Haven (sargramostim, topotecan HCl)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- sargramostim
- topotecan hydrochloride
-
New Haven, ConnecticutYale Comprehensive Cancer Center
Aug 13, 2020
Sarcoma, Kaposi, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Bleomycin sulfate
- +4 more
-
Los Angeles, California
- +4 more
Oct 26, 2021
Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)
Recruiting
- Neuroblastoma
- 131I-MIBG
- +4 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,
Active, not recruiting
- Bilateral Breast Carcinoma
- +11 more
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +11 more
Jan 12, 2023
Cytomegalovirus Retinitis, HIV Trial in United States (Zidovudine, Sargramostim, Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
- Zidovudine
- +2 more
-
Los Angeles, California
- +3 more
Oct 28, 2021